Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia

BACKGROUND: Despite the recent progress that has been made in the understanding and treatment of acute lymphoblastic leukemia (ALL), the outcome is still dismal in adult ALL cases. Several studies in solid tumors identified high expression of WEE1 kinase as a poor prognostic factor and reported its...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghelli Luserna Di Rorà, Andrea, Beeharry, Neil, Imbrogno, Enrica, Ferrari, Anna, Robustelli, Valentina, Righi, Simona, Sabattini, Elena, Verga Falzacappa, Maria Vittoria, Ronchini, Chiara, Testoni, Nicoletta, Baldazzi, Carmen, Papayannidis, Cristina, Abbenante, Maria Chiara, Marconi, Giovanni, Paolini, Stefania, Parisi, Sarah, Sartor, Chiara, Fontana, Maria Chiara, De Matteis, Serena, Iacobucci, Ilaria, Pelicci, Pier Giuseppe, Cavo, Michele, Yen, Timothy J., Martinelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090987/
https://www.ncbi.nlm.nih.gov/pubmed/30068368
http://dx.doi.org/10.1186/s13045-018-0641-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090987/
https://www.ncbi.nlm.nih.gov/pubmed/30068368
http://dx.doi.org/10.1186/s13045-018-0641-1

Ejemplares similares